COLLAPAT® II Sponge haemostatic bone substitute
COLLAPAT® II consists of a collagen support which contains ceramic hydroxypatite granules.
The hydroxypatite granules give the material its osteoconductive properties.
Hydroxypatite is the highest mineral component in enamel, dentine and mineralised bone. It resorbs slowly.
The collagen gives COLLAPAT® II its haemostatic power and is completely resorbed in a few weeks. The collagen is extracted from bovine dermis.
Recognised stages in the manufacturing process inactivate viruses as well as non-conventional transmissible agents such as Prions. These treatments ensure maximum microbiological safety,particularly regarding the causative agent of BSE.
The presence of collagen allows the bone cells to migrate to the bone substitute, therefore promoting bone regeneration1. In a few weeks, the bone growth (immature tissue) will turn into mature bone tissue. The bone substitute is completely colonised by healthy tissue following intense bone regeneration. The collagen matrix is replaced by newly synthesised bone.
For maxillofacial, oral and stomatology surgery
COLLAPAT® II is used for filling bone lesions during maxillofacial and odontostomatology surgery.
- After removal of wisdom teeth or impacted canine
- After removal of radicular dental cysts
- Periodontal pocket debridement
- Filling for sinus grafts
- Restoration of bone stock following avulsion, trauma or tumours prior to fitting of implants
COLLAPAT® II must not be used in patients with allergic predisposition or in the case of known allergy to collagen of bovine origin.
- COLLAPAT® II must be used in perfectly sterile operating conditions after appropriate preparation of the site to be treated.
- COLLAPAT® II can be cut, using surgical scissors, to the desired dimensions to facilitate its application.
- After being wet with tissue fluids, antibiotics or saline solution, COLLAPAT® II becomes soft and paste-like, making it easy to use to fill the cavity requiring treatment.
- Drainage is strongly recommended however the drains must not come into direct contact with COLLAPAT® II.
- Avoid rinsing the implanted area.
- Removal of COLLAPAT® II must not be performed, except in the case of post-surgical infection.
- In the case of widespread and very deep bone lesions or segment defects of more than 1 to 2 cm, autologous bone shavings or PRP (Platelet Rich Plasma) should be combined with COLLAPAT® II.
- Bone instabilities require supporting osteosynthesis.
The SYMATESE Collagen Technology Platform gives to COLLAPAT® II the unique specification :
- An alternative to autologous or allogeneic grafts.
- Immediate availability and unlimited treatment, compared to autologous bone and avoids comorbidity
- COLLAPAT® II is sterilised by a radiation dose of 25 kGy.
- COLLAPAT® II sponges are supplied in double packaging impenetrable by light and moisture, in single
boxes, apart from the 1 x 1 x 1 cm unit which is supplied in a box of 5.
- COLLAPAT® II must be kept at ambient temperature (+10 °C à +30 °C).
- COLLAPAT® II is the result of COLLAPAT technology that was brought to market in 1980.
Manufactured by: SYMATESE – Biotech Dental – 305, Allées de Craponne – 13300 Salon de Provence – France.
A simplified company limited by shares (S.A.S.) with a capital of €24,866,417 – Corporate and Trade Register of Salon de Provence: 795 001 304 – SIRET [business registration number]: 795 001 304 00018 – VAT No.: FR 31 79 500 13 04. For health professionals only. Before use, refer to the product use instructions. Medical device categorised as III in the list of reimbursed products under article L165-1 of the French Social Security Code. The COLLAPATII bone implant is only reimbursed in cases of orthopaedic surgery and not for oral or dental surgery. COLLAPAT® II holds the CE marking (European Conformity) from the certified organisation G-MED n°0459 and is a Class III implantable medical device manufactured by SYMATESE – Chaponost – FRANCE. Images are for representation purpose only.